Amgen’s Kyprolis found to increase cancer survival rate
A Phase 3 clinical study of Amgen’s multiple myeloma drug Kyprolis showed that it increased overall survival rate when paired with lenalidomide and dexamethasone versus just those two drugs alone. The drug reduced the risk of death by 21 percent, and patients lived 7.9 months longer when on a regimen that included Kyprolis than those Read More →
Curvature completes merger with SMS Systems
Curvature, an information technology network company based in Santa Barbara, announced the completion of its merger with Charlotte, N.C.-based SMS Systems on July 13. The combined company will retain the Curvature name but reveal new branding and integrated offerings on July 17. It will also be looking to expand resources at both its West Coast Read More →
Frontier Communications completes 1-for-15 reverse stock split
Frontier Communications completed a 1-for-15 reverse stock split on July 10, opening at $16.35 per share, with around 175 million shares outstanding. The company announced the split March 28 when it filed paperwork with the Securities and Exchange Commission, and the move was approved by shareholders and the board of directors May 10. Its market Read More →
Wireless deal could shake up Central Coast
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
More viewers tune into over-the-air digital television signals
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
UCSB Technology Management Program has new leader
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sienna Biopharmaceuticals files for $75 million IPO
Westlake Village biotechnology company Sienna Biopharmaceuticals filed for an initial public offering with the Securities and Exchange Commission on June 3, stating expectations to raise up to $74.75 million. Founded in 2010, the company develops clinical-stage topical therapies for inflammatory skin diseases and other conditions. ARCH Venture Partners and Venvest Capital led a $40 million Read More →
